{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Breast Cancer in Patients Younger Than 40 Years: Imaging, Assessment, and Management

Activity Steps

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the incidence and types of breast cancer seen in women younger than 40 years.
  2. Review imaging modalities for evaluating young women with suspected breast cancer.
  3. Explain updated protocols for high-risk screening in young women.

Learning Outcomes

By the conclusion of this activity, a majority of the participants will demonstrate knowledge of current recommendations for imaging, assessment, and management related to breast cancer in patients under age 40 by achieving a passing score on the posttest.
Price: $49.00

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: PGO0424
Published: Apr 2024
Expires: 6/5/2026
Required Passing Score: 8/10 (80%)
Authors: Danara Suleimenova, MD; Mohammad Eghtedari, MD, PhD; Rebecca Rakow-Penner, MD, PhD; Vivian Lim, MD; William Ladd, MD; Haydee Ojeda-Fournier, MD
Categories: Cancer , Oncology , Women's Health